Penicillin G potassium, non-sterile
![Penicillin G potassium, non-sterile](/img/v2021/product_image.png)
Product Description
Centrient Pharmaceuticals
![Centrient Pharmaceuticals](/c247415img_XL-comp247415.jpg)
-
NL
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
Specifications
Centrient Pharmaceuticals
![Centrient Pharmaceuticals](/c247415img_XL-comp247415.jpg)
-
NL
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Centrient Pharmaceuticals (29)
-
Product Flucloxacillin sodium compacted
Dsm Sinochem Pharmaceuticals provides wide range of semi-synthetic penicillins which includes flucloxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of c... -
Product Flucloxacillin sodium powder
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes flucloxacillin sodium powder. Characteristics: a crystalline powder, hygroscopic. Application: the product is suitable for the manufacture of dry syrup formulation. The appropriate excipients should be added. Therape... -
Product Nystatin micronized
Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin micronized. Characteristics: a microfine crystalline powder. Application: the product is suitable for the manufacture of (extemporaneous) oral suspensions. Therapeutic category: polyene antibiotic with antifungal act... -
Product Nystatin mycelium
Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin mycelium. Characteristics: an amorphous powder. Application: the product is used as an intermediate for the extraction of nystatin and as feed-additive. Therapeutic category: polyene antibiotic with antifungal activi... -
Product Nystatin powder
Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin powder. Characteristics: a crystalline powder. Application: the product is suitable among others for the manufacture of creams, ointments, tablets and vaginal tablets after the addition of the appropriate excipients.... -
Product Oxacillin sodium compacted
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes oxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of capsules ... -
Product Penicillin G potassium, non-sterile
Centrient Pharmaceuticals provides wide range of penicillin products which includes penicillin g potassium, non-sterile. Characteristics: a crystalline powder. Application: this product is suitable as a starting material for the manufacture of sterile penicillin g salts and the manufacture of beta- lactam ... -
Product Penicillin G procaine
Centrient Pharmaceuticals provides wide range of penicillin products which includes penicillin g procaine. Characteristics: a crystalline powder. Application: this product is suitable as medicated feed additive for veterinary use. Therapeutic category: narrow spectrum antibiotic. Contact us for more inform... -
Product Penicillin V
Centrient Pharmaceuticals provides wide range of drug products which includes penicillin v. Dosage form: film-coated tablets. Contact us for more information. -
Product Puricillin® Compacted (ampicillin trihydrate)
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes puricillin® compacted (ampicillin trihydrate). Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Granules are produced using green e... -
Product 6-amino-penicillanic acid (6-APA)
6-amino-penicillanic acid (6-APA) -
Product Amoxicillin
Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin. Dosage form: capsules; film-coated tablets; tablets; oral suspension; sachets. Contact us for more information.
Centrient Pharmaceuticals resources (10)
-
News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech
Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).
With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.
-
Technical Data Overview Available MAs
Available Marketing Authorizations -
News Centrient achieves 100% PNEC compliance
Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics. Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range. -
Brochure Finished Dosage Forms Portfolio
Centrient Pharmaceuticals is a business-to-business provider of generics FDFs, not marketing the products ourselves. Therefore, we do not compete with our customers in the end market. All our dossiers are readily available for out-licensing to our partners worldwide. We work primarily with Europe-based FDFs manufacturers. Customers can be confident that the origin, traceability, and quality of our products are impeccable. We offer a dual sourcing strategy and procurement excellence for our third-party-produced APIs. -
News Our PureActives® partnerships
With our innovative enzymatic platform, we've been changing the game for sustainable antibiotics and statins production, step by step. -
Brochure API Product Portflio
We are a leading business-to-business provider of generic APIs. We help to secure patient safety, by driving Quality to the next level. Our reputation for producing high-quality generic APIs is well-known throughout the industry. Additionally, our business-to-business customers using our enzymatically produced APIs enjoy the freedom to operate, as these technologies are protected by patents. -
News Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand -
Whitepaper Manufacturing sustainable antibiotics for the future
Achieving a PNEC-compliant supply chain -
News Our ESG Report 2021
Sustainability matters a great deal to everyone at Centrient Pharmaceuticals, it is core to our mission and essential in shaping our authentic and purposeful culture. Our ESG Ambition means that we not only ‘do what we say,’ but also we are eager to share the significant progress we are making and demonstrate our strong industry leadership position by ‘saying what we do.’ We are proud to share our latest ESG Report 2021 summing up our accomplishments as a company.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance